ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2311

Obstructive Sleep Apnea Syndrome in Patients with Psoriatic Arthritis and Its Relationship with Disease Activity and Comorbidities

Esther Toledano1, Carolina Cristina Chacón2, Cristina Hidalgo Calleja2, Belén Miguel2, Laura Blanco2, Ana Turrión3, Olga Compán4, Manuel Martín3, Susana Gómez2 and Carlos Montilla2, 1Rheumatology Service, San Carlos Clinical Hospital, Madrid, Spain, 2Rheumatology Service, University Hospital of Salamanca, Salamanca, Castilla y Leon, Spain, 3Rheumatology Service, University Hospital of Salamanca, Salamanca, Spain, 4Rheumatology Service, University Hospital of Salamanca, Carbajosa de la Sagrada, 37191, Spain

Meeting: ACR Convergence 2025

Keywords: functional status, Psoriatic arthritis, quality of care, sleep

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Obstructive sleep apnea syndrome (OSAS) is a chronic respiratory disorder characterized by intermittent upper airway collapse during sleep. This mechanism can trigger systemic inflammation and metabolic dysregulation. Psoriatic arthritis (PsA) is associated with metabolic syndrome and emotional disorders, both of which are classic comorbidities of OSAS. Given the established relationship between PsA and metabolic syndrome, an association between PsA and OSAS would be expected; however, no studies to date have explored this potential relationship.Therefore, the aim of this study was to evaluate the presence of OSAS and its association with clinical, inflammatory, and functional features, as well as sleep quality in a cohort of PsA patients.

Methods: A cross-sectional observational study was conducted with 247 PsA patients, classified according to the presence (n=22) or absence (n=225) of OSAS. Demographic, clinical, functional, disease activity, functional impairment, disease impact, sleep quality, and comorbidity variables were collected. Logistic regression analysis was performed to identify factors associated with OSAS.

Results: Patients with OSAS had a higher mean age (58 vs. 54 years; p=0.02) and higher body mass index (BMI) (29.7 vs. 25.4 kg/m²; p=0.02). Regarding inflammatory parameters, they exhibited greater disease activity (DAPSA 13.2 vs. 10.6; p=0.09) and a higher number of enthesitis sites according to mMASES (0.7 vs. 0.0; p=0.3), although not reaching statistical significance. Functionally, OSAS patients showed significantly greater impairment according to the HAQ-DI (1.1 vs. 0.3; p=0.002) and greater disease impact (PsAID-12: 3.8 vs. 2.8; p=0.04). They also presented higher levels of fatigue (FACIT-F: 30.5 vs. 38; p=0.04), anxiety (HADS-A: 7 vs. 5; p=0.02), depression (HADS-D: 7 vs. 3.5; p=0.005), and worse sleep quality (ISI 9.3 vs. 7.0; p=0.001). In logistic regression analysis, BMI was the only variable significantly associated with OSAS (OR: 1.1; 95% CI: 1.01–1.2; p=0.04).

Conclusion: OSAS was associated with obesity, greater functional impairment, higher levels of fatigue, anxiety, depression, and poorer sleep quality in PsA patients. These findings highlight the importance of early detection strategies for comorbidities and a multidisciplinary approach in the assessment of PsA patients, including evaluation for OSAS.

Supporting image 1


Disclosures: E. Toledano: None; C. Chacón: None; C. Hidalgo Calleja: None; B. Miguel: None; L. Blanco: None; A. Turrión: None; O. Compán: None; M. Martín: None; S. Gómez: None; C. Montilla: None.

To cite this abstract in AMA style:

Toledano E, Chacón C, Hidalgo Calleja C, Miguel B, Blanco L, Turrión A, Compán O, Martín M, Gómez S, Montilla C. Obstructive Sleep Apnea Syndrome in Patients with Psoriatic Arthritis and Its Relationship with Disease Activity and Comorbidities [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/obstructive-sleep-apnea-syndrome-in-patients-with-psoriatic-arthritis-and-its-relationship-with-disease-activity-and-comorbidities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obstructive-sleep-apnea-syndrome-in-patients-with-psoriatic-arthritis-and-its-relationship-with-disease-activity-and-comorbidities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology